Abstract:Background & aims: Dysregulated colonic epithelial cell (CEC) proliferation is a critical feature in the development of colorectal cancer. We show that NF-κB-inducing kinase (NIK) attenuates colorectal cancer through coordinating CEC regeneration/differentiation via noncanonical NF-κB signaling that is unique from canonical NF-kB signaling. Methods: Initial studies evaluated crypt morphology/functionality, organoid generation, transcriptome profiles, and the microbiome. Inflammation and inflammation-induced tumorigenesis were initiated in whole-body NIK knockout mice (Nik-/-) and conditional-knockout mice following administration of azoxymethane and dextran sulfate sodium. Results: Human transcriptomic data revealed dysregulated noncanonical NF-kB signaling. In vitro studies evaluating Nik-/- crypts and organoids derived from mature, nondividing CECs, and colonic stem cells exhibited increased accumulation and stunted growth, respectively. Transcriptomic analysis of Nik-/- cells revealed gene expression signatures associated with altered differentiation-regeneration. When assessed in vivo, Nik-/- mice exhibited more severe colitis with dextran sulfate sodium administration and an altered microbiome characterized by increased colitogenic microbiota. In the inflammation-induced tumorigenesis model, we observed both increased tumor burdens and inflammation in mice where NIK is knocked out in CECs (NikΔCEC). Interestingly, this was not recapitulated when NIK was conditionally knocked out in myeloid cells (NikΔMYE). Surprisingly, conditional knockout of the canonical pathway in myeloid cells (RelAΔMYE) revealed decreased tumor burden and inflammation and no significant changes when conditionally knocked out in CECs (RelAΔCEC). Conclusions: Dysregulated noncanonical NF-κB signaling is associated with the development of colorectal cancer in a tissue-dependent manner and defines a critical role for NIK in regulating gastrointestinal inflammation and regeneration associated with colorectal cancer.

high expression of NF-κB inducing kinase in the bulge region of hair follicle induces tumor

Attribution of NF-κB Activity to CHUK/IKKα-Involved Carcinogenesis

A NIK-IKKα Module Expands ErbB2-Induced Tumor-Initiating Cells by Stimulating Nuclear Export of P27/kip1

Enhanced Anti-Tumor Response Upon Deficiency of Msn Kinase MINK1 in Mice

NF-κB Inducing Kinase Attenuates Colorectal Cancer by Regulating Noncanonical NF-κB Mediated Colonic Epithelial Cell Regeneration

NIK is a component of the EGF/heregulin receptor signaling complexes

NIK is a component of the EGF|[sol]|heregulin receptor signaling complexes

Deletion of IKKβ in activated fibroblasts promotes tumor progression in melanoma

Impaired Dnkap Function Drives Genome Instability and Tumorigenic Growth in Drosophila Epithelia.

An Atypical E3 Ligase Zinc Finger Protein 91 Stabilizes and Activates NF-κB-inducing Kinase Via Lys63-linked Ubiquitination

Chronic epithelial NF-κB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation

Bi-compartmental communication contributes to the opposite proliferative behavior of Notch1-deficient hair follicle and epidermal keratinocytes

Signalling by senescent melanocytes hyperactivates hair growth

Cell intrinsic role of NF-κB-inducing kinase in regulating T cell-mediated immune and autoimmune responses

Dickkopf‐1 Drives Perineural Invasion Via PI3K–AKT Signaling Pathway in Head and Neck Squamous Cancer

Medullary Thymic Epithelial NF-kB-inducing Kinase (nik)/ikkα Pathway Shapes Autoimmunity and Liver and Lung Homeostasis in Mice.

NF-kBActivation Upregulates PKM2 Expression and Promotes Tumorigenesis

Pluripotency Factor Nanog is Tumorigenic by Deregulating DNA Damage Response in Somatic Cells

An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice

Nuclear Factor-κB Enhances ErbB2-Induced Mammary Tumorigenesis and Neoangiogenesis in Vivo

Nuclear versus cytoplasmic IKKα signaling in keratinocytes leads to opposite skin phenotypes and inflammatory responses, and a different predisposition to cancer